Paul S. Covington

1.5k total citations
37 papers, 1.2k citations indexed

About

Paul S. Covington is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, Paul S. Covington has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Gastroenterology, 16 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Paul S. Covington's work include Gastrointestinal motility and disorders (27 papers), Gastroesophageal reflux and treatments (12 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Paul S. Covington is often cited by papers focused on Gastrointestinal motility and disorders (27 papers), Gastroesophageal reflux and treatments (12 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Paul S. Covington collaborates with scholars based in United States, Ireland and United Kingdom. Paul S. Covington's co-authors include David Andrae, Leonard S. Dove, James M. Davenport, Gail McIntyre, Anthony Lembo, Brian E. Lacy, Brooks D. Cash, Qais Mekki, Aziz Karim and P. Fleck and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Paul S. Covington

37 papers receiving 1.1k citations

Peers

Paul S. Covington
Masaharu Takeyama Japan
Julie E. Stevens Australia
R. C. Heading United Kingdom
K Jonderko Poland
Marisa Chiloiro Italy
John M. Wo United States
Christian de Mey Germany
René Menguy United States
H Bliesath Germany
Nordin M.J. Hanssen Netherlands
Masaharu Takeyama Japan
Paul S. Covington
Citations per year, relative to Paul S. Covington Paul S. Covington (= 1×) peers Masaharu Takeyama

Countries citing papers authored by Paul S. Covington

Since Specialization
Citations

This map shows the geographic impact of Paul S. Covington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Covington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Covington more than expected).

Fields of papers citing papers by Paul S. Covington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul S. Covington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Covington. The network helps show where Paul S. Covington may publish in the future.

Co-authorship network of co-authors of Paul S. Covington

This figure shows the co-authorship network connecting the top 25 collaborators of Paul S. Covington. A scholar is included among the top collaborators of Paul S. Covington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul S. Covington. Paul S. Covington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Lucinda A., Lin Chang, Susan Lucak, et al.. (2018). A169 EFFICACY AND SAFETY OF ELUXADOLINE IN ELDERLY PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA. Journal of the Canadian Association of Gastroenterology. 1(suppl_2). 252–253. 1 indexed citations
2.
Afghani, Elham, Simon K. Lo, Paul S. Covington, Brooks D. Cash, & Stephen J. Pandol. (2017). Sphincter of Oddi Function and Risk Factors for Dysfunction. Frontiers in Nutrition. 4. 1–1. 74 indexed citations
3.
Lacy, Brian E., William D. Chey, Brooks D. Cash, et al.. (2017). Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. The American Journal of Gastroenterology. 112(6). 924–932. 42 indexed citations
4.
Fant, Reginald V., Jack E. Henningfield, Brooks D. Cash, Leonard S. Dove, & Paul S. Covington. (2017). Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clinical Gastroenterology and Hepatology. 15(7). 1021–1029.e6. 15 indexed citations
5.
Chey, William D., Leonard S. Dove, David Andrae, & Paul S. Covington. (2017). Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies. Alimentary Pharmacology & Therapeutics. 45(10). 1319–1328. 23 indexed citations
6.
Cash, Brooks D., Brian E. Lacy, Philip Schoenfeld, Leonard S. Dove, & Paul S. Covington. (2016). Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. The American Journal of Gastroenterology. 112(2). 365–374. 60 indexed citations
7.
Lembo, Anthony, Brian E. Lacy, Marc J. Zuckerman, et al.. (2016). Eluxadoline for Irritable Bowel Syndrome with Diarrhea. New England Journal of Medicine. 374(3). 242–253. 228 indexed citations
8.
Levy‐Cooperman, Naama, Gail McIntyre, Mark E. McDonnell, et al.. (2016). Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 359(3). 471–481. 24 indexed citations
9.
Harris, Lucinda A., Susan Lucak, Lin Chang, et al.. (2016). Impact of Baseline Pain Severity on the Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. The American Journal of Gastroenterology. 111. S254–S254. 1 indexed citations
10.
Lacy, Brian E., David Andrae, James M. Davenport, et al.. (2015). Su1378 Robustness of Eluxadoline for the Treatment of Irritable Bowel Syndrome With Diarrhea: Results From Phase 3 Composite Endpoint Assessments. Gastroenterology. 148(4). S–491. 5 indexed citations
11.
Cash, Brooks D., Philip Schoenfeld, Brian E. Lacy, Leonard S. Dove, & Paul S. Covington. (2015). Adverse Event Profile of Eluxadoline Over Time in Patients With Irritable Bowel Syndrome With Diarrhea. The American Journal of Gastroenterology. 110. S748–S749. 2 indexed citations
12.
Lembo, Anthony, et al.. (2014). Urgency as a Measure of Treatment Effect Due to Eluxadoline. The American Journal of Gastroenterology. 109. S542–S543. 2 indexed citations
13.
Andrae, David, Donald L. Patrick, Douglas A. Drossman, & Paul S. Covington. (2013). Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health and Quality of Life Outcomes. 11(1). 208–208. 82 indexed citations
14.
Dove, Leonard S., Anthony Lembo, Charles Randall, et al.. (2013). Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study. Gastroenterology. 145(2). 329–338.e1. 119 indexed citations
15.
Davenport, James M., Paul S. Covington, Mark H. Gotfried, et al.. (2012). Summary of Pharmacokinetics and Tissue Distribution of a Broad‐Spectrum Fluoroquinolone, JNJ‐Q2. Clinical Pharmacology in Drug Development. 1(4). 121–130. 11 indexed citations
16.
Covington, Paul S., David Andrae, Charles Randall, et al.. (2012). 943e MuDelta Treatment Improves Bowel Movement Frequency and Urgency Episodes in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Results of a Phase 2 Clinical Trial. Gastroenterology. 142(5). S–161. 1 indexed citations
17.
Karim, Aziz, Paul S. Covington, Rita Christopher, et al.. (2010). Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 48(1). 46–58. 34 indexed citations
18.
19.
Christopher, Ronald, Paul S. Covington, Miles P. Davenport, et al.. (2008). Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. Clinical Therapeutics. 30(3). 513–527. 106 indexed citations
20.
Abraham, Edward, Youn C. Park, Paul S. Covington, Steven A. Conrad, & Michael Schwartz. (1996). Liposomal prostaglandin E sub 1 in acute respiratory distress syndrome. Critical Care Medicine. 24(1). 10–15. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaharu Takeyama Breakdown of academic impact, for papers by Julie E. Stevens Breakdown of academic impact, for papers by R. C. Heading Breakdown of academic impact, for papers by K Jonderko Breakdown of academic impact, for papers by Marisa Chiloiro Breakdown of academic impact, for papers by John M. Wo Breakdown of academic impact, for papers by Christian de Mey Breakdown of academic impact, for papers by René Menguy Breakdown of academic impact, for papers by H Bliesath Breakdown of academic impact, for papers by Nordin M.J. Hanssen
Rankless by CCL
2026